Effect of a Nutritional Supplement on H&N Cancer Patients
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2006 by Edward Hines Jr. VA Hospital.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Edward Hines Jr. VA Hospital
Information provided by:
Edward Hines Jr. VA Hospital
ClinicalTrials.gov Identifier:
NCT00296452
First received: February 23, 2006
Last updated: NA
Last verified: February 2006
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To determine if using a nutritionally enhanced supplement will improve mucositis in head and neck cancer patients
| Condition | Intervention |
|---|---|
|
Head and Neck Cancer |
Behavioral: behavior |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Factorial Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | The Effect of an Enhanced Nutritional Supplement on Head and Neck Cancer Patients |
Resource links provided by NLM:
Further study details as provided by Edward Hines Jr. VA Hospital:
Primary Outcome Measures:
- severity of mucositis
Secondary Outcome Measures:
- weight loss, quality of life
| Estimated Enrollment: | 40 |
| Study Start Date: | February 2006 |
| Estimated Study Completion Date: | February 2006 |
H&N cancer patients will be randomized to receive either a nutritionally enhanced product or standard treatment. The patients in both groups will receive nutritional counseling weekly by the RD. Anthropometric measures, available lab values, mucositis grade, and quality of life measures will be compared between groups.
Eligibility| Ages Eligible for Study: | 30 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Head and neck cancer 1st.2nd wk Rx read &wrte eng
Exclusion Criteria:
- receiving hospice impaired cognition
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00296452
Contacts
| Contact: Sharon Foley, MS | 708-202-2343 ext 22343 | Sharon.Foley@med.va.gov |
Locations
| United States, Illinois | |
| Hines VA Hospital | Suspended |
| Hines, Illinois, United States, 60141 | |
| Edward Hines, Jr. VA Hospital | Recruiting |
| Hines, Illinois, United States, 60141 | |
| Contact: Sharon Foley, MS 708-202-2343 ext 22343 Sharon.Foley@med.va.gov | |
Sponsors and Collaborators
Edward Hines Jr. VA Hospital
Investigators
| Principal Investigator: | Sharon Foley, MS | Hines VA Hosptial |
| Principal Investigator: | carol bier-laning, MD | Hines VA Hospital |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00296452 History of Changes |
| Other Study ID Numbers: | 0033 |
| Study First Received: | February 23, 2006 |
| Last Updated: | February 23, 2006 |
| Health Authority: | United States: Federal Government |
Keywords provided by Edward Hines Jr. VA Hospital:
|
cancer nutrition |
Additional relevant MeSH terms:
|
Head and Neck Neoplasms Neoplasms by Site Neoplasms |
ClinicalTrials.gov processed this record on May 16, 2013